We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
423
Increased
3,809
Reduced
3,216
Closed
305

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Technology 24.63%
2 Financials 9.78%
3 Healthcare 7.32%
4 Industrials 7.25%
5 Consumer Discretionary 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TELO icon
8176
Telomir Pharmaceuticals
TELO
$82.5M
$6 ﹤0.01%
+5
New +$7
ARTW icon
8177
Arts-Way Manufacturing Co
ARTW
$15.4M
$5 ﹤0.01%
1
AZIO
8178
Azio AI Holdings
AZIO
$19.6M
$5 ﹤0.01%
3
GV
8179
DELISTED
Visionary Holdings
GV
$5 ﹤0.01%
24
-7
-23% -$2
NTIP icon
8180
Network-1 Technologies
NTIP
$35.7M
$5 ﹤0.01%
3
PSHG icon
8181
Performance Shipping
PSHG
$21.3M
$5 ﹤0.01%
3
GITS
8182
Global Interactive Technologies
GITS
$5.66M
$5 ﹤0.01%
+2
New +$4
LHAI
8183
Linkhome Holdings
LHAI
$13.9M
$5 ﹤0.01%
+8
New +$8
AIFA
8184
All In FutureTech Alliance Inc
AIFA
$20.3M
$4 ﹤0.01%
+2
New +$5
FABC
8185
Fabric.AI Inc
FABC
$19.4M
$4 ﹤0.01%
1
CHNR icon
8186
China Natural Resources
CHNR
$5.29M
$4 ﹤0.01%
1
SSM
8187
Sono Group N.V.
SSM
$4.22M
$4 ﹤0.01%
1
AAME icon
8188
Atlantic American Corp
AAME
$26.3M
$3 ﹤0.01%
1
CANF
8189
Can-Fite BioPharma American Depositary Shares
CANF
$7.18M
$3 ﹤0.01%
1
CETX icon
8190
Cemtrex
CETX
$4.58M
$3 ﹤0.01%
+1
New +$8
DRMA icon
8191
Dermata Therapeutics
DRMA
$7.78M
$3 ﹤0.01%
+2
New +$3
GNPX icon
8192
Genprex
GNPX
$3.29M
0
SDEV
8193
Stablecoin Development Corp
SDEV
$51.1M
$3 ﹤0.01%
3
NCNA
8194
NuCana
NCNA
$6.28M
$3 ﹤0.01%
2
SLE icon
8195
Super League Enterprise
SLE
$186M
$3 ﹤0.01%
1
VVOS icon
8196
Vivos Therapeutics
VVOS
$5.63M
$3 ﹤0.01%
7
ATER icon
8197
Aterian
ATER
$8.1M
$2 ﹤0.01%
1
BIAF icon
8198
bioAffinity Technologies
BIAF
$2.86M
0
FRSX
8199
Foresight Autonomous Holdings
FRSX
$4.99M
$2 ﹤0.01%
1
HUBCZ icon
8200
Hub Cyber Security Warrant
HUBCZ
$69.4K
$2 ﹤0.01%
100

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.